AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+8.91%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$149M
AUM Growth
+$149M
(-15%)
Cap. Flow
-$34.7M
Cap. Flow
% of AUM
-23.3%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
297
New
63
Increased
40
Reduced
80
Closed
81
Top Buys
| 1 |
ABVX
Abivax
ABVX
|
$2.86M |
| 2 |
Pfizer
PFE
|
$2.3M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
$2.1M |
| 4 |
Invesco QQQ Trust
QQQ
|
$2.1M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
$1.93M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$3.38M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$2.95M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$2.78M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
$2.74M |
| 5 |
TSVT
2seventy bio
TSVT
|
$2.58M |
Sector Composition
| 1 | Healthcare | 59.47% |
| 2 | Real Estate | 11.94% |
| 3 | Financials | 4.93% |
| 4 | Industrials | 2.46% |
| 5 | Consumer Discretionary | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERE
51
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.06M | 0.71% |
+25,000
| New | +$1.06M |
|
52
Stereotaxis
STXS
$246M
| $1.05M | 0.7% |
600,000
| – | – |
|
53
Karyopharm Therapeutics
KPTI
$61.4M
| $973K | 0.65% |
1,125,000
| – | – |
|
|
54
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $930K | 0.62% |
11,340
-33,850
| -75% | -$2.78M |
|
|
ONIT
55
Onity Group Inc.
ONIT
$339M
| $867K | 0.58% |
28,195
| – | – |
|
56
Mobileye
MBLY
$11.1B
| $866K | 0.58% |
20,000
| – | – |
|
57
AGNC Investment
AGNC
$10.4B
| $830K | 0.56% |
84,646
| – | – |
|
58
Acadia Pharmaceuticals
ACAD
$4.34B
| $814K | 0.55% |
26,000
-24,000
| -48% | -$751K |
|
59
Omnicell
OMCL
$1.51B
| $753K | 0.51% |
20,000
+5,000
| +33% | +$188K |
|
60
Gilead Sciences
GILD
$140B
| $689K | 0.46% |
8,500
| – | – |
|
61
Protagonist Therapeutics
PTGX
$3.62B
| $688K | 0.46% |
30,000
-13,500
| -31% | -$310K |
|
62
Nuvation Bio
NUVB
$1.08B
| $680K | 0.46% |
450,000
+40,000
| +10% | +$60.4K |
|
63
Roivant Sciences
ROIV
$8.6B
| $618K | 0.41% |
55,000
+20,000
| +57% | +$225K |
|
64
iRhythm Technologies
IRTC
$5.67B
| $535K | 0.36% |
5,000
-2,000
| -29% | -$214K |
|
65
iShares 3-7 Year Treasury Bond ETF
IEI
$16.8B
| $535K | 0.36% |
+4,568
| New | +$535K |
|
66
Helix Energy Solutions
HLX
$952M
| $514K | 0.35% |
50,000
-10,000
| -17% | -$103K |
|
67
Cardinal Health
CAH
$36B
| $509K | 0.34% |
5,053
+218
| +5% | +$22K |
|
68
JPMorgan BetaBuilders Japan ETF
BBJP
$13.7B
| $501K | 0.34% |
9,545
-1,430
| -13% | -$75.1K |
|
69
iShares MSCI Australia ETF
EWA
$1.51B
| $491K | 0.33% |
+20,188
| New | +$491K |
|
|
NNDM
70
Nano Dimension
NNDM
$296M
| $480K | 0.32% |
200,000
| – | – |
|
71
PACCAR
PCAR
$50.5B
| $451K | 0.3% |
4,618
+2,018
| +78% | +$197K |
|
72
Aurinia Pharmaceuticals
AUPH
$1.58B
| $450K | 0.3% |
50,000
| – | – |
|
73
SoundHound AI
SOUN
$5.19B
| $424K | 0.28% |
200,000
| – | – |
|
74
Viatris
VTRS
$12.3B
| $379K | 0.25% |
35,000
-12,500
| -26% | -$135K |
|
75
SPDR Bloomberg Convertible Securities ETF
CWB
$4.39B
| $378K | 0.25% |
5,242
-592
| -10% | -$42.7K |
|